Russell Investments Group Ltd. Takes Position in Tempus AI, Inc. $TEM

Russell Investments Group Ltd. acquired a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 5,381 shares of the company's stock, valued at approximately $260,000.

A number of other large investors have also recently bought and sold shares of the business. Arrowpoint Investment Partners Singapore Pte. Ltd. acquired a new position in shares of Tempus AI during the first quarter valued at approximately $311,000. HighTower Advisors LLC acquired a new stake in shares of Tempus AI during the 1st quarter valued at $320,000. Virtu Financial LLC acquired a new stake in shares of Tempus AI in the 1st quarter valued at $4,029,000. Invesco Ltd. bought a new position in Tempus AI in the 1st quarter worth $337,000. Finally, Benjamin Edwards Inc. increased its holdings in shares of Tempus AI by 19.9% during the 1st quarter. Benjamin Edwards Inc. now owns 43,137 shares of the company's stock worth $2,081,000 after purchasing an additional 7,149 shares during the period. Institutional investors own 24.22% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on TEM shares. HC Wainwright began coverage on shares of Tempus AI in a research report on Tuesday. They issued a "buy" rating and a $90.00 price target on the stock. Bank of America lifted their price target on shares of Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a research note on Wednesday, June 25th. Guggenheim boosted their price objective on shares of Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a research note on Monday, June 30th. Piper Sandler restated a "neutral" rating on shares of Tempus AI in a research report on Friday, August 8th. Finally, BTIG Research raised their target price on shares of Tempus AI from $75.00 to $85.00 and gave the company a "buy" rating in a research report on Wednesday, August 20th. Seven analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $69.50.

Insider Activity at Tempus AI

In other news, EVP Andrew Polovin sold 5,398 shares of the business's stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total transaction of $402,960.70. Following the completion of the sale, the executive vice president directly owned 132,056 shares of the company's stock, valued at approximately $9,857,980.40. The trade was a 3.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Eric P. Lefkofsky sold 332,500 shares of the company's stock in a transaction dated Wednesday, August 27th. The stock was sold at an average price of $74.10, for a total transaction of $24,638,250.00. Following the completion of the sale, the chief executive officer directly owned 9,207,533 shares of the company's stock, valued at approximately $682,278,195.30. This trade represents a 3.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 1,108,951 shares of company stock worth $77,660,938 in the last 90 days. Insiders own 26.27% of the company's stock.

Tempus AI Trading Up 3.3%

NASDAQ TEM traded up $2.48 during trading on Tuesday, hitting $78.34. The company had a trading volume of 9,399,118 shares, compared to its average volume of 11,744,468. The company has a quick ratio of 1.43, a current ratio of 1.54 and a debt-to-equity ratio of 2.58. The company's fifty day moving average is $64.71 and its 200-day moving average is $59.20. Tempus AI, Inc. has a one year low of $31.36 and a one year high of $91.45.

Tempus AI (NASDAQ:TEM - Get Free Report) last released its quarterly earnings data on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, beating analysts' consensus estimates of ($0.23) by $0.01. The business had revenue of $314.64 million during the quarter, compared to analyst estimates of $296.84 million. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. Tempus AI's revenue was up 89.5% compared to the same quarter last year. During the same period last year, the business earned ($6.86) EPS. Tempus AI has set its FY 2025 guidance at EPS. Equities research analysts expect that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.